Form 8-K - Current report:
SEC Accession No. 0001628280-19-000602
Filing Date
2019-01-28
Accepted
2019-01-28 17:24:57
Documents
1
Period of Report
2019-01-28
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K a8k-caldolornextgen012019.htm 8-K 24443
  Complete submission text file 0001628280-19-000602.txt   25446
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 19546489
SIC: 2834 Pharmaceutical Preparations